# Prescribing Asthma Controller Medication According to Gene Status to Improve Quality of Life in Young People With Asthma

> **NCT02758873** · NA · COMPLETED · sponsor: **University of Sussex** · enrollment: 241 (actual)

## Conditions studied

- Asthma

## Interventions

- **GENETIC:** Personalised medicine (Salmeterol)
- **GENETIC:** Personalised medicine (Montelukast)
- **OTHER:** Standard care

## Key facts

- **NCT ID:** NCT02758873
- **Lead sponsor:** University of Sussex
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2019-07
- **Final completion:** 2019-07
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2020-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02758873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02758873, "Prescribing Asthma Controller Medication According to Gene Status to Improve Quality of Life in Young People With Asthma". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02758873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*